Geron
GERN
#6280
Rank
S$1.08 B
Marketcap
S$1.70
Share price
3.15%
Change (1 day)
-68.13%
Change (1 year)

Geron (GERN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.41 Billion

According to Geron's latest financial reports the company's total liabilities are S$0.41 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Geron - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.42 B120.78%
2023-12-31S$0.19 B30.19%
2022-12-31S$0.14 B10.07%
2021-12-31S$0.13 B70.29%
2020-12-31S$79.08 M93.21%
2019-12-31S$40.93 M296.8%
2018-12-31S$10.31 M18.37%
2017-12-31S$8.71 M-23.48%
2016-12-31S$11.38 M21.36%
2015-12-31S$9.38 M-83.01%
2014-12-31S$55.23 M474.57%
2013-12-31S$9.61 M-44.44%
2012-12-31S$17.3 M-0.63%
2011-12-31S$17.41 M-66.91%
2010-12-31S$52.61 M380.21%
2009-12-31S$10.95 M-1.3%
2008-12-31S$11.1 M-41.65%
2007-12-31S$19.02 M-73.53%
2006-12-31S$71.88 M69.02%
2005-12-31S$42.53 M165.76%
2004-12-31S$16 M-20.11%
2003-12-31S$20.03 M-62.67%
2002-12-31S$53.66 M-16.43%
2001-12-31S$64.21 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
S$3.37 M-99.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$48.04 B 11,534.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.72 B 75.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$2.17 B 426.92%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S$0.17 B-56.82%๐Ÿ‡บ๐Ÿ‡ธ USA